Lower serum 15-HETE level predicts nasal ILC2 accumulation during COX-1 inhibition in AERD

被引:8
作者
Badrani, Jana H. [1 ,2 ]
Cavagnero, Kellen [1 ]
Eastman, Jacqueline J. [1 ]
Kim, Alex S. [1 ]
Strohm, Allyssa [1 ,2 ]
Yan, Carol [3 ]
Deconde, Adam [3 ]
Zuraw, Bruce L. [1 ,2 ]
White, Andrew A. [4 ]
Christiansen, Sandra C. [1 ]
Doherty, Taylor A. [1 ,5 ]
机构
[1] Univ Calif San Diego, Dept Med, Sect Allergy & Immunol, La Jolla, CA USA
[2] Vet Affairs San Diego Healthcare Syst, La Jolla, CA USA
[3] Univ Calif San Diego, Dept Otolaryngol, San Diego, CA USA
[4] Scripps Clin, Div Allergy Asthma & Immunol, La Jolla, CA USA
[5] Univ Calif San Diego, Dept Med, Biomed Sci Bldg, Room 5090, 9500 Gilman Dr, La Jolla, CA 92093 USA
基金
美国国家卫生研究院;
关键词
ILC2; innate lymphoid cells; AERD; asthma; nasal polyps; eicosanoid; lipidomic; 15-HETE; 19; 20-diHDPA; EXACERBATED RESPIRATORY-DISEASE; PROSTAGLANDIN E-2; ASPIRIN; RESISTANCE; LIPOXINS; DRIVEN;
D O I
10.1016/j.jaci.2023.06.028
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: Aspirin-exacerbated respiratory disease (AERD) is associated with high levels of cysteinyl leukotrienes, prostaglandin D2, and low levels of prostaglandin E2. Further, 15-hydroxyeicosatetraenoic acid (15-HETE) levels may have predictive value in therapeutic outcomes of aspirin desensitization. Accumulation of nasal group 2 innate lymphoid cells (ILC2s) has been demonstrated during COX-1 inhibition in AERD, although the relationships between tissue ILC2 accumulation, reaction symptom severity, and novel lipid biomarkers are unknown. Objective: We sought to determine whether novel lipid mediators are predictive of nasal ILC2 accumulation and symptom scores during COX-1 inhibitor challenge in patients with AERD. Methods: Blood and nasal scraping samples from patients with AERD were collected at baseline and COX-1 inhibitor reaction and then processed for flow cytometry for nasal ILC2s and serum for lipidomic analysis. Results: Eight patients with AERD who were undergoing aspirin desensitization were recruited. Of the 161 eicosanoids tested, 42 serum mediators were detected. Baseline levels of 15-HETE were negatively correlated with the change in numbers of airway ILC2s (r = -0.6667; P = .0428). Docosahexaenoic acid epoxygenase metabolite 19,20-dihydroxy-4Z,7Z,10Z,13Z,16Z-docosapentaenoic acid (19,20-diHDPA) was positively correlated with both changes in airway ILC2s (r = 0.7143; P = .0305) and clinical symptom scores (r = 0.5000; P = .0081). Conclusion: Low levels of baseline 15-HETE predicted a greater accumulation of airway ILC2s in patients with AERD who were receiving COX-1 inhibition. Further, increases in the cytochrome P pathway metabolite 19,20-dihydroxy- 4Z,7Z,10Z,13Z,16Z-docosapentaenoic acid (19,20-diHDPA) were associated with increased symptoms and nasal ILC2 accumulation. Future studies to assess how these mediators might control ILC2s may improve the understanding of AERD pathogenesis. (J Allergy Clin Immunol 2023;152:1330-35.)
引用
收藏
页码:1330 / +
页数:7
相关论文
共 25 条
[1]   Cellular interactions in aspirin-exacerbated respiratory disease [J].
Badrani, Jana H. ;
Doherty, Taylor A. .
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 21 (01) :65-70
[2]   Metabolomic analysis identifies potential diagnostic biomarkers for aspirin-exacerbated respiratory disease [J].
Ban, G. -Y. ;
Cho, K. ;
Kim, S. -H. ;
Yoon, M. K. ;
Kim, J. -H. ;
Lee, H. Y. ;
Shin, Y. S. ;
Ye, Y. -M. ;
Cho, J. -Y. ;
Park, H. -S. .
CLINICAL AND EXPERIMENTAL ALLERGY, 2017, 47 (01) :37-47
[3]   Lipoxin A4 Regulates Natural Killer Cell and Type 2 Innate Lymphoid Cell Activation in Asthma [J].
Barnig, Cindy ;
Cernadas, Manuela ;
Dutile, Stefanie ;
Liu, Xiaoli ;
Perrella, Mark A. ;
Kazani, Shamsah ;
Wechsler, Michael E. ;
Israel, Elliot ;
Levy, Bruce D. .
SCIENCE TRANSLATIONAL MEDICINE, 2013, 5 (174)
[4]   Mild COVID-19 imprints a long-term inflammatory eicosanoid-and chemokine memory in monocyte-derived macrophages [J].
Bohnacker, Sina ;
Hartung, Franziska ;
Henkel, Fiona ;
Quaranta, Alessandro ;
Kolmert, Johan ;
Priller, Alina ;
Ud-Dean, Minhaz ;
Giglberger, Johanna ;
Kugler, Luisa M. ;
Pechtold, Lisa ;
Yazici, Sarah ;
Lechner, Antonie ;
Erber, Johanna ;
Protzer, Ulrike ;
Lingor, Paul ;
Knolle, Percy ;
Chaker, Adam M. ;
Schmidt-Weber, Carsten B. ;
Wheelock, Craig E. ;
Esser-von Bieren, Julia .
MUCOSAL IMMUNOLOGY, 2022, 15 (03) :515-524
[5]   Impaired E Prostanoid2 Expression and Resistance to Prostaglandin E2 in Nasal Polyp Fibroblasts from Subjects with Aspirin-Exacerbated Respiratory Disease [J].
Cahill, Katherine N. ;
Raby, Benjamin A. ;
Zhou, Xiaobo ;
Guo, Feng ;
Thibault, Derek ;
Baccarelli, Andreas ;
Byun, Hyang-Min ;
Bhattacharyya, Neil ;
Steinke, John W. ;
Boyce, Joshua A. ;
Laidlaw, Tanya M. .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2016, 54 (01) :34-40
[6]   Prostaglandin D2: A dominant mediator of aspirin-exacerbated respiratory disease [J].
Cahill, Katherine N. ;
Bensko, Jillian C. ;
Boyce, Joshua A. ;
Laidlaw, Tanya M. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 135 (01) :245-252
[7]   ASPIRIN TRIGGERS PREVIOUSLY UNDESCRIBED BIOACTIVE EICOSANOIDS BY HUMAN ENDOTHELIAL CELL-LEUKOCYTE INTERACTIONS [J].
CLARIA, J ;
SERHAN, CN .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (21) :9475-9479
[8]   Group 2 innate lymphoid cells are recruited to the nasal mucosa in patients with aspirin-exacerbated respiratory disease [J].
Eastman, Jacqueline J. ;
Cavagnero, Kellen J. ;
Deconde, Adam S. ;
Kim, Alex S. ;
Karta, Maya R. ;
Broide, David H. ;
Zuraw, Bruce L. ;
White, Andrew A. ;
Christiansen, Sandra C. ;
Doherty, Taylor A. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 140 (01) :101-+
[9]   Innate immune cell dysregulation drives inflammation and disease in aspirin-exacerbated respiratory disease [J].
Eid, Ryan ;
Yan, Carol H. ;
Stevens, Whitney ;
Doherty, Taylor A. ;
Borish, Larry .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 148 (02) :309-318
[10]   Plasma 15-Hydroxyeicosatetraenoic Acid Predicts Treatment Outcomes in Aspirin-Exacerbated Respiratory Disease [J].
Jerschow, Elina ;
Edin, Matthew L. ;
Pelletier, Teresa ;
Abuzeid, Waleed M. ;
Akbar, Nadeem A. ;
Gibber, Marc ;
Fried, Marvin ;
Lih, Fred B. ;
Gruzdev, Artiom ;
Bradbury, J. Alyce ;
Han, Weiguo ;
Hudes, Golda ;
Keskin, Taha ;
Schuster, Victor L. ;
Spivack, Simon ;
Zeldin, Darryl C. ;
Rosenstreich, David .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2017, 5 (04) :998-+